EBS
Emergent Biosolutions, Inc.
stockNYSE
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.06 | 2026-11-06 | -4.62% | 0.852 |
| 1M | 6.91 | 2026-10-13 | -16.35% | 0.658 |
| 3M | 4.49 | 2026-08-13 | +28.73% | 0.814 |
| 6M | 8.33 | 2026-05-13 | -30.61% | 0.544 |
| 1Y | 10.32 | 2025-11-13 | -43.99% | 1.114 |
| 2Y | 9.97 | 2024-11-13 | -42.03% | — |
| 5Y | 36.94 | 2021-11-12 | -84.35% | 1.684 |
Emergent Biosolutions, Inc. (NYSE:EBS) stock price today is $5.78, and today's volume is 680,538. EBS is down 1.868% today. The 30 day average volume is 1.13M. EBS market cap is $297.18M with 51.42M shares outstanding.